Mary-Keara Boss (M K Boss)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Topics

Metastatic Renal Cell Carcinoma

Tyrosine Kinase

Chronic Rhinosinusitis

Small Cell Lung Cancer

Top Venues

Veterinary and comparative oncology

International journal of molecular sciences

International journal of radiation biology

Journal of veterinary internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Johnny Altwal, Ber-In Lee, Mary-Keara Boss, Susan M LaRue, Tiffany Wormhoudt Martin
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy. Veterinary and comparative oncology (2024)
Amber R Prebble, Bailey Latka, Braden Burdekin, Del Leary, Mac Harris, Daniel Regan, Mary-Keara Boss
Investigation of Gastrointestinal Toxicities Associated with Concurrent Abdominal Radiation Therapy and the Tyrosine Kinase Inhibitor Sunitinib in a Mouse Model. International journal of molecular sciences 25 (3) (2024)
Johnny Altwal, Ber-In Lee, Mary-Keara Boss, Susan M LaRue, Tiffany Wormhoudt Martin
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy. Veterinary and comparative oncology 22 (1) (2024)
Amber R Prebble, Bailey Latka, Braden Burdekin, Del Leary, Mac Harris, Daniel Regan, Mary-Keara Boss
Investigation of Gastrointestinal Toxicities Associated with Concurrent Abdominal Radiation Therapy and the Tyrosine Kinase Inhibitor Sunitinib in a Mouse Model. International journal of molecular sciences 25 (3) (2024)
Johnny Altwal, Ber-In Lee, Mary-Keara Boss, Susan M LaRue, Tiffany Wormhoudt Martin
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy. Veterinary and comparative oncology (2024)
Johnny Altwal, Ber-In Lee, Mary-Keara Boss, Susan M LaRue, Tiffany Wormhoudt Martin
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy. Veterinary and comparative oncology 22 (1) (2024)
Amber R Prebble, Bailey Latka, Braden Burdekin, Del Leary, Mac Harris, Daniel Regan, Mary-Keara Boss
Investigation of Gastrointestinal Toxicities Associated with Concurrent Abdominal Radiation Therapy and the Tyrosine Kinase Inhibitor Sunitinib in a Mouse Model. International journal of molecular sciences 25 (3) (2024)
Amber R Prebble, Bailey Latka, Braden Burdekin, Del Leary, Mac Harris, Daniel Regan, Mary-Keara Boss
Investigation of Gastrointestinal Toxicities Associated with Concurrent Abdominal Radiation Therapy and the Tyrosine Kinase Inhibitor Sunitinib in a Mouse Model. International journal of molecular sciences 25 (3) (2024)
Johnny Altwal, Ber-In Lee, Mary-Keara Boss, Susan M LaRue, Tiffany Wormhoudt Martin
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy. Veterinary and comparative oncology 22 (1) (2024)
Amber R Prebble, Bailey Latka, Braden Burdekin, Del Leary, Mac Harris, Daniel Regan, Mary-Keara Boss
Investigation of Gastrointestinal Toxicities Associated with Concurrent Abdominal Radiation Therapy and the Tyrosine Kinase Inhibitor Sunitinib in a Mouse Model. International journal of molecular sciences 25 (3) (2024)
Erin Trageser, Tiffany Wormhoudt Martin, Braden Burdekin, Cullen Hart, Del Leary, Susan LaRue, Mary-Keara Boss
Efficacy of stereotactic radiation therapy for the treatment of confirmed or presumed canine glioma. Veterinary and comparative oncology (2023)
Alicja I Reczynska, Susan M LaRue, Mary-Keara Boss, Ber-In Lee, Del Leary, Kelsey Pohlmann, Lynn R Griffin, Susan Lana, Tiffany Wormhoudt Martin
Outcome of stereotactic body radiation for treatment of nasal and nasopharyngeal lymphoma in 32 cats. Journal of veterinary internal medicine 36 (2) (2022)
Erin Trageser, Tiffany Wormhoudt Martin, Elizabeth Hoaglund, Del Leary, Susan LaRue, Mary-Keara Boss
Outcomes of dogs with thymoma treated with intensity modulated stereotactic body radiation therapy or non-modulated hypofractionated radiation therapy. Veterinary and comparative oncology 20 (2) (2022)
Michael William Knitz, Thomas E Bickett, Laurel B Darragh, Ayman J Oweida, Shilpa Bhatia, Benjamin Van Court, Shiv Bhuvane, Miles Piper, Jacob Gadwa, Adam C Mueller, Diemmy Nguyen, Varuna Nangia, Douglas G Osborne, Xiyuan Bai, Sarah E Ferrara, Mary-Keara Boss, Andrew Goodspeed, Matthew A Burchill, Beth Ann Jiron Tamburini, Edward D Chan, Curtis R Pickering, Eric T Clambey, Sana D Karam
Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis. Journal for immunotherapy of cancer 9 (4) (2021)
Mary-Keara Boss
Canine comparative oncology for translational radiation research. International journal of radiation biology (2021)
Ber-In Lee, Mary-Keara Boss, Susan M LaRue, Tiffany Wormhoudt Martin, Del Leary
Comparative study of the collapsed cone convolution and Monte Carlo algorithms for radiation therapy planning of canine sinonasal tumors reveals significant dosimetric differences. Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association (2021)
Tiffany Wormhoudt Martin, Lynn R Griffin, James Custis, Stewart D Ryan, Mary Lafferty, Mary-Keara Boss, Daniel P Regan, Sangeeta Rao, Del Leary, Stephen J Withrow, Susan M LaRue
Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs. Veterinary and comparative oncology 19 (2) (2021)
Ber-In Lee, Susan M LaRue, Bernard Séguin, Lynn R Griffin, Amber R Prebble, Tiffany Wormhoudt Martin, Del Leary, Mary-Keara Boss
Safety and efficacy of stereotactic body radiation therapy (SBRT) for the treatment of canine thyroid carcinoma. Veterinary and comparative oncology 18 (4) (2020)
Mary-Keara Boss, M W Dewhirst, R S Sampaio, A Bennett, A Tovmasyan, K G Berman, A W Beaven, D A Rizzieri, I Batinic-Haberle, M L Hauck, I Spasojevic
Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy. Cancer chemotherapy and pharmacology 80 (2) (2017)